<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02487355</url>
  </required_header>
  <id_info>
    <org_study_id>IRB000087123</org_study_id>
    <nct_id>NCT02487355</nct_id>
  </id_info>
  <brief_title>Pediatric Caudal Dexmedetomidine Enhances Postoperative Analgesia of Magnesium Sulphate in Lower Abdominal Surgeries</brief_title>
  <acronym>JASayed</acronym>
  <official_title>Pediatric Caudal Epidural Dexmedetomidine Enhances Postoperative Analgesia of Magnesium Sulphate and Quality of Caudal Anesthesia in Lower Abdominal Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will conduct to compare the efficacy of Magnesium sulphate &amp; dexmedetomidine used
      as adjuvants to bupivacaine in caudal block to provide intra-operative anesthesia as well as
      post -operative analgesia in pediatric patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      asdsd
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to first analgesic requirement</measure>
    <time_frame>24 hours</time_frame>
    <description>The time from end of surgery to the first requirement of postoperative analgesia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative sedation scores</measure>
    <time_frame>24 hours</time_frame>
    <description>Level of sedation was recorded throughout the post-anesthesia care unit stay at 15-minute time intervals</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>group (MG)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Magnesium sulfate 50 mg add to 1 ml/kg of 0.25%of bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group (D)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexmedetomidine 1 μg/ kg to add to 1ml/kg of 0.25%of bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group (MD)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>50 mg magnesium sulfate and Dexmedetomidine 1 μg/ kg to add to 1ml/kg of 0.25%of bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group (C)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1ml/kg of 0.25%of bupivacaine + 1 ml of normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Dexmedetomidine 1 μg/ kg</description>
    <arm_group_label>group (D)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulphate</intervention_name>
    <description>Magnesium Sulphate 50 mg</description>
    <arm_group_label>group (MG)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>1ml/kg of 0.25%of bupivacaine</description>
    <arm_group_label>group (C)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine + Magnesium Sulphate + Bupivacaine</intervention_name>
    <description>Dexmedetomidine 1 μg/ kg + Magnesium Sulphate 50 mg + 1ml/kg of 0.25%of bupivacaine</description>
    <arm_group_label>group (MD)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male and female children, ASA I and II,Aged 6 months to 6 years, , undergoing
             elective surgical procedures expected to last more than 90 min, and scheduled to
             receive general anesthesia combined with caudal extradural block

        Exclusion Criteria:

          -  Allergy to local anesthetics,coagulation disorders, infection at site of injection,
             anatomic abnormalities and congenital anomalies like spina bifid, ASA III or higher,
             Parental refusal and the current use of Calcium Channel Blockers or Medication that
             may affect the neurologic system
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>jehan A Sayed, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>assistant professor in anesthesia and intensive care department,faculty of medicine,Assiut univeristy,egypt</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jehan A Sayed, MD</last_name>
    <phone>+2 01006253939</phone>
    <email>jehan.alloul@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>mohamed amir, MD</last_name>
    <phone>+01005689353</phone>
    <email>dr.amir63@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assiut Univeristy Hospital</name>
      <address>
        <city>Assiut</city>
        <zip>715715</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jehan A sayed, MD</last_name>
      <phone>+2 01006253939</phone>
      <email>jehan.alloul@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2015</study_first_submitted>
  <study_first_submitted_qc>June 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2015</study_first_posted>
  <last_update_submitted>September 25, 2017</last_update_submitted>
  <last_update_submitted_qc>September 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>jehan ahmed sayed</investigator_full_name>
    <investigator_title>Associate Professor (Anesthesiology and Critical Care)- College of Medicine</investigator_title>
  </responsible_party>
  <keyword>dexmedetomidine</keyword>
  <keyword>magnesium sulphate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Magnesium Sulfate</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

